Search for Symbols, analysts, keywords

FSTX F-star Therapeutics, Inc.
Stock Price & Overview

FSTX is defunct since March 10, 2023.

Analysis

News

Latest Headlines

F-star Therapeutics surges as buyer Sino Biopharma gains CFIUS approval

CDTX, PTGX and TAST among premarket gainers

F-star Therapeutics surges on report sale to Sino Biopharma close to CFIUS approval

F-star Therapeutics jumps as it extends walk date with buyer to `finalize' CFIUS agreement

Heightened U.S.-China Tensions Threaten F-Star Deal

F-star Therapeutics gains after deal termination date with buyer extended again

F-star Therapeutics gains as buyer Sino Biopharma cancels Shanghai listing

Catalyst watch: Google talks AI, Nordstrom drama and Canada Goose event

F-star Therapeutics up 18% as it extends end date of merger with invoX Pharma

F-star's Delayed Acquisition Presents A Risky Opportunity

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.